Weekly Steroids in Muscular Dystrophy (WSiMD)
Open Label Safety and Efficacy of Once Weekly Steroid in Patients With LGMD and Becker Muscular Dystrophy
Sponsor: Northwestern University
A PHASE2 clinical study on Becker Muscular Dystrophy and Limb-girdle Muscular Dystrophy, this trial is completed. The trial is conducted by Northwestern University and has accumulated 10 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Oct 2023 — Jul 2024 [monthly]
Completed PHASE2
-
Mar 2023 — Oct 2023 [monthly]
Completed PHASE2
Status: Active Not Recruiting → Completed
-
Feb 2022 — Mar 2023 [monthly]
Active Not Recruiting PHASE2
▶ Show 5 earlier versions
-
Dec 2021 — Feb 2022 [monthly]
Active Not Recruiting PHASE2
-
Sep 2021 — Dec 2021 [monthly]
Active Not Recruiting PHASE2
-
Jan 2021 — Sep 2021 [monthly]
Active Not Recruiting PHASE2
-
Jul 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE2
Status: Enrolling By Invitation → Active Not Recruiting
-
Sep 2019 — Jul 2020 [monthly]
Enrolling By Invitation PHASE2
First recorded
Jul 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Northwestern University
For direct contact, visit the study record on ClinicalTrials.gov .